Mark Buzza

1.2k citations

16 papers · 553 indexed · h-index 12

Impact in

Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
Nephrology top 2%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes

Papers in ⓘ

Hematology 5
- Hemophilia Treatment and Research 2
- Hemostasis and retained surgical items 2
Immunology and Allergy 4
- Cell Adhesion Molecules Research 4

Co-authors: Judy Savige (7 shared papers)Hayat Dagher (5 shared papers)D. J. Wilson (3 shared papers)Kesha Rana (3 shared papers)Yan Yan Wang (2 shared papers)Stephen Tonna (1 shared paper)Liliana L. Bove (2 shared papers)Timothy Colin Bednall (2 shared papers)
Journals: Kidney International (4 papers)Transfusion (3 papers)American Journal of Kidney Diseases (2 papers)JAMA Oncology (1 paper)Annals of Human Biology (1 paper)
Partner nations: Australia United States Canada

In The Last Decade

Mark Buzza

15 papers receiving 544 citations

Peers

Countries citing papers authored by Mark Buzza

Since Specialization

Citations

This map shows the geographic impact of Mark Buzza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Buzza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Buzza more than expected).

Fields of papers citing papers by Mark Buzza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Buzza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Buzza. The network helps show where Mark Buzza may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Buzza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Buzza Line = papers co-authored together Mark Buzza links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Thin basement membrane nephropathy Kidney International ·Judy Savige, Kesha Rana, Stephen Tonna, Mark Buzza, Hayat Dagher, Yan Yan Wang	2003	165
2	Mutations in the COL4A4 gene in thin basement membrane disease Kidney International ·Mark Buzza, Hayat Dagher, YanYan Wang, D. J. Wilson, Jeffrey J. Babon, Richard G.H. Cotton, Judy Savige	2003	54
3	Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome Kidney International ·Mark Buzza, D. J. Wilson, Judy Savige	2001	54
4	Understanding the plasmapheresis donor in a voluntary, nonremunerated environment Transfusion ·Liliana L. Bove, Timothy Colin Bednall, Barbara Masser, Mark Buzza	2011	51
5	COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome11See Editorial by Monnens, p. 799 Kidney International ·Mark Buzza, Yan Yan Wang, Hayat Dagher, Jeffrey J. Babon, Richard G.H. Cotton, Harley R. Powell, John P. Dowling, Judy Savige	2001	51
6	A comparison of the clinical, histopathologic, and ultrastructural phenotypes in carriers of X-linked and autosomal recessive Alport's syndrome American Journal of Kidney Diseases ·Hayat Dagher, Mark Buzza, Deb Colville, Colin L. Jones, Harley Powell, R. G. Fassett, D. J. Wilson, John Agar, Judy Savige	2001	47
7	Perceived deterrents to being a plasmapheresis donor in a voluntary, nonremunerated environment Transfusion ·Kathleen L. Bagot, Liliana L. Bove, Barbara Masser, Timothy Colin Bednall, Mark Buzza	2012	43
8	Apolipoprotein AI and CIII gene polymorphisms and their association with lipid levels in Italian, Greek and Anglo-Irish populations of Australia Annals of Human Biology ·Mark Buzza, YJ Fripp, R. John Mitchell	2001	18
9	The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs Nature Reviews Urology ·Michelle M. Kouspou, Jenna E. Fong, Nadine Brew, Sarah Hsiao, Seanna Davidson, Peter L. Choyke, Tony Crispino, Suneil Jain, Guido Jenster, Beatrice S. Knudsen, Jeremy Millar, Nicole Mittmann, Charles J. Ryan, Bertrand Tombal, Mark Buzza	2020	15
10	Persistent familial hematuria in children and the locus for thin basement membrane nephropathy Pediatric Nephrology ·Kesha Rana, Yan Yan Wang, Harley R. Powell, Colin L. Jones, David A. McCredie, Mark Buzza, Madhara Udawela, Judy Savige	2005	13
11	A prospective trial assessing the safety and efficacy of collecting up to 840 mL of plasma in conjunction with saline infusion during plasmapheresis Transfusion ·Mark Buzza, Denese C. Marks, Hugh Capper, E Cassin, Caro‐Anne Badcock, Samantha Reid, Matthew Kwok, Hung‐Chih Yang, June Lee, Carolyn Corrigan, Tanja Hartkopf‐Theis, A. J. Keller	2012	12
12	Decentralized Clinical Trials as a New Paradigm of Trial Delivery to Improve Equity of Access JAMA Oncology ·Craig Underhill, Jessica Freeman, Jacqueline Dixon, Mark Buzza, Donna Long, Kate Burbury, Sabe Sabesan, Jacqueline McBurnie, Anne Woollett	2024	12
13	Clinical, histopathologic, and genetic studies in nine families with focal segmental glomerulosclerosis American Journal of Kidney Diseases ·Kesha Rana, Nicole M. Isbel, Mark Buzza, Hayat Dagher, Paul Henning, Gad Kainer, Judy Savige	2003	11
14	Intense exercise for survival among men with metastatic castrate-resistant prostate cancer (INTERVAL – MCRPC): A Movember funded multicenter, randomized, controlled phase III study. Journal of Clinical Oncology ·Fred Saad, Stacey A. Kenfield, June M. Chan, Nicolas H. Hart, Kerry S. Courneya, James W.F. Catto, Stephen P. Finn, Rosemary Greenwood, Daniel C. Hughes, Lorelei A. Mucci, Stephen R. Plymate, Michaël Pollak, Stephan Praet, Aaron P. Russell, Emer Guinan, Erin Van Blarigan, Órla Casey, Mark Buzza, Charles J. Ryan, Robert U. Newton	2016	4
15	Aligning organisational priorities and implementation science for cancer research BMC Health Services Research ·Stephanie Best, Karin Thursky, Mark Buzza, Marlena Klaic, Sanne Peters, Lisa Guccione, Alison H. Trainer, Jill Francis	2024	3
16	Development of a virtual multidisciplinary meeting framework for less common cancers Internal Medicine Journal ·Ian Collins, Jessica Freeman, Justin Ludowyk, John E. McDonough, James Ridgwell, Mark Buzza, Niall M. Corcoran, David Campbell, Benjamin Thomas	2025	0

About Mark Buzza

Mark Buzza is a scholar working on Hematology, Immunology and Allergy, Nephrology, Management of Technology and Innovation and Public Health, Environmental and Occupational Health, having authored 16 papers that have together received 553 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (4 papers), Renal Diseases and Glomerulopathies (3 papers), Blood donation and transfusion practices (3 papers), Hemophilia Treatment and Research (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Blood transfusion and management (2 papers), Hemostasis and retained surgical items (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Immunology and Allergy (213 citations), Nephrology (240 citations), Management of Technology and Innovation (101 citations), Hematology (98 citations) and Genetics (86 citations). Mark Buzza has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Judy Savige, Hayat Dagher, D. J. Wilson, Kesha Rana, Yan Yan Wang, Stephen Tonna, Liliana L. Bove, Timothy Colin Bednall, Barbara Masser and Richard G.H. Cotton. Their work appears in journals such as Kidney International, Transfusion, American Journal of Kidney Diseases, JAMA Oncology and Annals of Human Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact